# Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2

> **NCT00931372** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 22 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Lixisenatide (AVE0010)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00931372
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00931372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00931372, "Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00931372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*